Biomedical professor Quing Zhu, PhD, and her team created the imaging technique, acoustic resolution photoacoustic microscopy coregistered with ultrasound, and paired it with artificial intelligence, according to a March 26 news release. The imaging was better at identifying residual tumors in treated rectal bed tissues.
AR-PAM/US imaging was better at discerning residual cancer from scar tissue compared to other techniques such as an MRI. Results of the research were published in Radiology March 23.
“Our PAM/US system paired with the deep learning neural network has great potential to better identify patients suitable for nonoperative management and improve patient quality of life,” Dr. Zhu said. “If we can tell after radiation and chemotherapy which patients may have a good response with no residual tumors, the patient may be able to avoid surgery.”
More articles on surgery centers:
Surgery Partners breaks ground on Missouri ASC in joint venture
The smartest thing 7 ASC execs did last year
How ASCs are preparing for spike in CMS approvals
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.